Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftaroline in Neonates and Young Infants with Late-onset Sepsis
NCT02424734Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Aug 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of ceftaroline fosamil in late-onset neonatal sepsis (LONS), sponsored by Pfizer. Started Aug 2015; status: terminated.
02
Drugs
ceftaroline fosamil
03
Conditions
late-onset neonatal sepsis (LONS)
Beyond the preview
Go deeper on NCT02424734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02424734.